(Quartz) – Demand for weight loss drugs like Ozempic is also boosting diagnoses of conditions such as sleep apnea and cardiovascular disease

Popular weight-loss drugs like Wegovy and Zepbound are boosting the use of healthcare in the U.S., leading to an uptick in patients getting diagnosed and starting prescriptions for other conditions, according to a new analysis by health data firm Truveta. (Read More)